0001104659-21-067336.txt : 20210517 0001104659-21-067336.hdr.sgml : 20210517 20210517070328 ACCESSION NUMBER: 0001104659-21-067336 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210513 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (China) IV L.P. CENTRAL INDEX KEY: 0001726030 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21927497 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (Cayman) IV L.P. CENTRAL INDEX KEY: 0001726029 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21927496 BUSINESS ADDRESS: STREET 1: 4 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 4 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax IV GP L.P. CENTRAL INDEX KEY: 0001726353 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21927494 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (Israel) IV, L.P. CENTRAL INDEX KEY: 0001726039 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21927495 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax Management 4 G.P. (2015) Ltd. CENTRAL INDEX KEY: 0001726334 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 21927498 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001035354 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 841368850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (858) 909-0749 MAIL ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Sevion Therapeutics, Inc. DATE OF NAME CHANGE: 20140930 FORMER COMPANY: FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC DATE OF NAME CHANGE: 19991006 FORMER COMPANY: FORMER CONFORMED NAME: NAVA LEISURE USA INC DATE OF NAME CHANGE: 19970310 4 1 tm2116620d3_4.xml FORM 4 X0306 4 2021-05-13 0 0001035354 Eloxx Pharmaceuticals, Inc. ELOX 0001726334 Pontifax Management 4 G.P. (2015) Ltd. C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 0 0 1 0 0001726030 Pontifax (China) IV L.P. C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 0 0 1 0 0001726029 Pontifax (Cayman) IV L.P. C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 0 0 1 0 0001726039 Pontifax (Israel) IV, L.P. C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 0 0 1 0 0001726353 Pontifax IV GP L.P. C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451 0 0 1 0 Common Stock 2021-05-13 4 P 0 1280624 1.35 A 1791470 I By Pontifax Investment Fund Common Stock 2021-05-13 4 P 0 2630487 1.35 A 3679797 I By Pontifax Investment Fund Common Stock 2021-05-13 4 P 0 1422222 1.35 A 1989551 I By Pontifax Investment Fund Common Stock 2021-05-13 4 P 0 592592 1.35 A 616592 I By Pontifax Investment Fund Reflects the purchase of shares in the offering of Common Stock of Eloxx Pharmaceuticals, Inc. that is expected to close on May 18, 2021. Represents shares of the Issuer held by Pontifax (Cayman) IV L.P. ("Cayman IV"). Pontifax IV GP L.P. ("Pontifax IV") is the general partner of Cayman IV. Pontifax Management 4 G.P. (2015) Ltd. ("Management 4") is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Cayman IV. Each of Management 4, Pontifax IV and Cayman IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Represents shares of the Issuer held by Pontifax (Israel) IV, L.P. ("Israel IV"). Pontifax IV is the general partner of Israel IV. Management 4 is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Israel IV. Each of Management 4, Pontifax IV and Israel IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Represents shares of the Issuer held by Pontifax (China) IV L.P. ("China IV"). Pontifax IV is the general partner of China IV. Management 4 is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by China IV. Each of Management 4, Pontifax IV and China IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Represents shares of the Issuer held by Pontifax Late Stage Fund L.P.("Late Stage Fund"). Pontifax Late Stage GP Ltd. ("Late Stage GP"), the general partner of Late Stage Fund, has a Strategic Alliance Agreement with Pontifax IV. By virtue of this relationship, Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Late Stage Fund. Each of Management 4, Pontifax IV, Late Stage Fund and Late Stage GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Pontifax Management 4 G.P. (2015) Ltd. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer 2021-05-17 Pontifax (China) IV L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer 2021-05-17 Pontifax (Cayman) IV L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer 2021-05-17 Pontifax (Israel) IV, L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer 2021-05-17 Pontifax IV GP L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer 2021-05-17